These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Comparative study of the effectiveness of average therapeutic doses of sustac and obzidan in patients with exertional angina pectoris]. Nazarenko VA; Savvateev KL; Mazur NA Kardiologiia; 1982 Sep; 22(9):42-6. PubMed ID: 6815367 [No Abstract] [Full Text] [Related]
28. Effect of practolol on exercise tolerance in patients with angina pectoris. Sowton E; Smithen C; Leaver D; Barr I Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290 [No Abstract] [Full Text] [Related]
29. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris. Rezaković DE; Lakatos S; Stalec J; Pavicić L Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489 [TBL] [Abstract][Full Text] [Related]
30. Peripheral hemodynamic effects of oral controlled-release nitroglycerin (Nitrong) in man. Hirshleifer I Curr Ther Res Clin Exp; 1973 Apr; 15(4):158-64. PubMed ID: 4633276 [No Abstract] [Full Text] [Related]
31. Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability. Roy P; Day L; Sowton E Br Med J; 1975 Jul; 3(5977):195-7. PubMed ID: 238716 [TBL] [Abstract][Full Text] [Related]
32. [Duration of the hemodynamic effect of various doses of delayed-action nitroglycerin preparations]. Savvateev KL; Metelitsa VI; Vygodin VA Kardiologiia; 1983 Feb; 23(2):55-61. PubMed ID: 6405071 [TBL] [Abstract][Full Text] [Related]
33. Excessive reduction in peripheral resistance during exercise and risk of orthostatic symptoms with sustained-release nitroglycerin and diltiazem treatment of angina. Bruce RA; Hossack KF; Kusumi F; Day B; Kannagi T Am Heart J; 1985 May; 109(5 Pt 1):1020-6. PubMed ID: 3922207 [TBL] [Abstract][Full Text] [Related]
34. Glyceryl trinitrate ointment in angina pectoris. Salem HH; Singh SP Postgrad Med J; 1979 Dec; 55(654):874-6. PubMed ID: 121456 [TBL] [Abstract][Full Text] [Related]
35. Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise. Prichard BN; Gillam PM Br Heart J; 1971 Jul; 33(4):473-80. PubMed ID: 4997528 [No Abstract] [Full Text] [Related]
36. [Nitrite therapy of stenocardia]. Meesmann W; Amann L Dtsch Med Wochenschr; 1971 Sep; 96(36):1444-9. PubMed ID: 4397998 [No Abstract] [Full Text] [Related]
37. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests. Bjerle P; Jacobsson KA Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804 [No Abstract] [Full Text] [Related]
38. Double-blind crossover study of diphenylhydantoin in angina pectoris. Taylor CR Chest; 1974 Oct; 66(4):422-7. PubMed ID: 4213041 [No Abstract] [Full Text] [Related]
39. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial. Crean PA; Ribeiro P; Crea F; Davies GJ; Ratcliffe D; Maseri A Am Heart J; 1984 Dec; 108(6):1494-500. PubMed ID: 6439019 [TBL] [Abstract][Full Text] [Related]
40. Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin. Goldstein RE; Rosing DR; Redwood DR; Beiser GD; Epstein SE Circulation; 1971 May; 43(5):629-40. PubMed ID: 4996159 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]